Bank of Montreal’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Bank of Montreal’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,500	Closed	-$2.03K	–	4443
2023 Q4	$2.03K	Hold	12,500	–	–	﹤0.01%	3895
2023 Q3	$4.01K	Hold	12,500	–	–	﹤0.01%	3684
2023 Q2	$1.63K	Hold	12,500	–	–	﹤0.01%	3896
2023 Q1	$1.39K	Hold	12,500	–	–	﹤0.01%	3723
2022 Q4	$625	Hold	12,500	–	–	﹤0.01%	3909
2022 Q3	$1	Hold	12,500	–	–	﹤0.01%	4019
2022 Q2	$1	Buy	+12,500	New	+$2.77K	﹤0.01%	4023

Other funds holding CLDI.WS

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Bank of Montreal's CLDI.WS Position: Q1 2024 in Review

Bank of Montreal sold out of Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS) in Q1 2024, closing a stake of 12,500 shares — an estimated $2.03K sold.

Bank of Montreal first reported a position in CLDI.WS in Q2 2022 and held it in 7 quarters. The position peaked at $4.01K in Q3 2023. 16 funds tracked by Wall St. Rank hold CLDI.WS as of Q1 2024.

Bank of Montreal reported no remaining Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position as of Q1 2024 after selling out during the quarter.
Bank of Montreal sold 12,500 Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 shares in Q1 2024, an estimated $2.03K.
Bank of Montreal first reported a position in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in Q2 2022 and held it in 7 quarters.
Bank of Montreal's Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position peaked at $4.01K in Q3 2023.
16 funds tracked by Wall St. Rank held Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.